naringenin has been researched along with Apoplexy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Huang, J; Huang, L; Liang, M; Liang, X; Luo, N; Wang, K; Xie, W | 1 |
| Bai, X; Chen, L; Zhang, J; Zhang, L; Zhang, X; Zhao, T; Zhao, X; Zhao, Y | 1 |
2 other study(ies) available for naringenin and Apoplexy
| Article | Year |
|---|---|
Naringenin prevents ischaemic stroke damage via anti-apoptotic and anti-oxidant effects.
Topics: Active Transport, Cell Nucleus; Animals; Antioxidants; Apoptosis; Cell Nucleus; Cell Proliferation; Cytoprotection; Flavanones; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Mitochondria; Neurons; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Stroke | 2017 |
Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-κB, MMP-9 and up-regulated claudin-5 expression.
Topics: Animals; Brain Ischemia; Claudin-5; Down-Regulation; Flavanones; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; NF-kappa B; Nod2 Signaling Adaptor Protein; Rats; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinase 2; Stroke; Up-Regulation | 2014 |